If this is the case and Oncosec has really no intention of selling the company, then we have funding of $30 mil + 12.2 mil shares added to the count.....this is dilution so the data better be good or next year we see another dilution. We need Pisces to enroll faster and get to an approval....so far delays have killed this stock.